The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various ...

The modified Medical Research Council (mMRC) dyspnea scale was the first questionnaire developed to measure breathlessness, which is a key symptom in many patients with COPD, although often ...

As frontline partners, PCPs coordinate work-up, referrals, and lifestyle counseling in dyspnea. Review essential steps for ...

The primary outcome of severe chronic breathlessness was defined as a modified MRC breathlessness scale score of 3 or 4 (score range 0-10), corresponding to patients' reports of being "too ...

WASHINGTON — Dyspnea, pain and reduced mobility were frequently reported in survivors of COVID-19 1 year after hospitalization, according to an abstract presented at the American Thoracic ...

The article discussed the causes and treatments of dyspnea, or breathlessness, which is often linked to heart or lung issues. It highlighted the importance of proper diagnosis and named specific ...

At baseline and weeks 8 (primary end point), 16, and 24, participants completed measures of dyspnea (Modified Medical Research Council Dyspnea Scale [mMRCDS]; Cancer Dyspnoea Scale [CDS]), quality of ...

From baseline to day 56 after treatment, scores on the NRS (a 0-10 scale where higher scores indicate more severe breathlessness) dropped from a mean 6.5 to 6.4 in the mirtazapine group while ...

Citing several studies that supported the use of BNP in patients with dyspnea and with comorbid heart and lung disease, Le Jemtel et al. suggested that BNP >500 pg/mL is indicative of overt ...

No evidence was observed for a difference in worst breathlessness per NRS score at day 56 between patients who received mirtazapine and placebo, with a difference in adjusted mean NRS score ...